Agnoli G C, Borgatti R, Cacciari M, Ikonomu E, Lenzi P, Marinelli M
Cattedra di Semeiotica Medica, dell'Università, Bologna, Italy.
Clin Physiol. 1992 Jan;12(1):79-93. doi: 10.1111/j.1475-097x.1992.tb00295.x.
The hypothesis that potassium depletion (KD) might play a role in stimulating the renal synthesis of prostanoids, and that these materials can contribute to hypokalaemic renal dysfunction, has been tested. Healthy women were studied either in normal potassium balance (N,n = 14), or in experimental KD. KD was induced by low dietary potassium intake (less than or equal to 10 mmol day-1) and natriuretic treatment, associated with replacement of net NaCl and water loss. By using different depletive patterns, two groups with estimated cumulative potassium deficits of 160 +/- 43 mmol (KD1, n = 8) and 198 +/- 22 mmol (KD2, n = 6), respectively, were obtained. Renal function by the clearance (cl.) method and urinary PGE2, 6-keto-PGF1 alpha, TxB2 concentrations by the RIA method were measured during hypotonic polyuria (oral water load) and subsequent moderate antidiuresis induced by the infusion of low-dose lysine-8-vasopressin (LVP). Compared to the N group, only in the KD2 group do glomerular and tubular dysfunctions typical of hypokalaemia and reduced prostanoid excretions (significant for 6-keto-PGF1 alpha and TxB2 but not for PGE2) appear during polyuria besides the significant reductions of plasma potassium concentration, urinary potassium excretion and the significant increase in plasma renin activity. During LVP infusion the urinary prostanoid excretions were all significantly lower in absence of significant differences in urinary flow rate. Concerning its renal effects, LVP lost its ability to reduce the creatinine cl., while expressing a trend towards reduction in fractional chloride excretion. Indomethacin pretreatment restored the LVP effect on creatinine cl. and increased the antichloruretic LVP effect (although not significantly). To the extent that urinary prostanoid excretions reflect their intrarenal synthesis, our data demonstrate that KD inhibits this biosynthesis. A depressed production of prostanoids endowed with vasodilating and chloruretic activity probably played a role in attenuating the renal vascular hyporeactivity and the urinary chloride dispersion induced by KD.
钾缺乏(KD)可能在刺激肾脏合成前列腺素中起作用,且这些物质可能导致低钾血症性肾功能障碍,这一假说已得到验证。对健康女性进行了研究,她们分别处于正常钾平衡状态(N组,n = 14)或实验性KD状态。通过低膳食钾摄入(≤10 mmol/天)和利钠治疗诱导KD,并补充净失钠和失水量。采用不同的耗竭模式,分别获得了估计累积钾缺乏量为160±43 mmol的两组(KD1组,n = 8)和198±22 mmol的两组(KD2组,n = 6)。在低渗性多尿期(口服水负荷)以及随后静脉输注低剂量赖氨酸 - 8 - 加压素(LVP)诱导的中度抗利尿期,通过清除率(cl.)法测定肾功能,通过放射免疫分析法(RIA)测定尿PGE2、6 - 酮 - PGF1α、TxB2浓度。与N组相比,仅在KD2组中,除了血浆钾浓度、尿钾排泄显著降低以及血浆肾素活性显著增加外,多尿期还出现了低钾血症典型的肾小球和肾小管功能障碍以及前列腺素排泄减少(6 - 酮 - PGF1α和TxB2显著减少,但PGE2未减少)。在输注LVP期间,尿前列腺素排泄均显著降低,而尿流率无显著差异。关于其肾脏效应,LVP失去了降低肌酐清除率的能力,同时在氯排泄分数方面呈现降低趋势。吲哚美辛预处理恢复了LVP对肌酐清除率的作用,并增强了LVP的抗氯利尿作用(尽管不显著)。就尿前列腺素排泄反映其肾内合成而言,我们的数据表明KD抑制了这种生物合成。具有血管舒张和氯利尿活性的前列腺素生成减少可能在减轻KD诱导的肾血管反应性降低和尿氯排泄增加中起作用。